Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 2.7. It has been cited 117 times, with 83 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.716
From this paper's citation signal
Citation Network Contribution
1.9
From 64 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 83 citers.
Open Philanthropy Project
Grant: 2020-215611
National Institutes of Health
Grant: U01 AI149644
National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00051
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201400008C
National Institutes of Health
Grant: 1U01AI149644-01
Respiratory Virus Vaccine and Adjuvant Exploration
JPB Foundation
FWCI
1.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals